939807-28-0

Basic information

• Product Name: ethyl 3-(3-fluoro-4-nitrophenyl)-3-oxopropanoate
• Synonyms: ethyl 3-(3-fluoro-4-nitrophenyl)-3-oxopropanoate
• CAS NO: 939807-28-0
• Molecular Weight: 255.203
• Mol File: 939807-28-0.mol

Chemical Properties

• CAS DataBase Reference: ethyl 3-(3-fluoro-4-nitrophenyl)-3-oxopropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(3-fluoro-4-nitrophenyl)-3-oxopropanoate(939807-28-0)
• EPA Substance Registry System: ethyl 3-(3-fluoro-4-nitrophenyl)-3-oxopropanoate(939807-28-0)

Safety Data

• Hazardous Substances Data: 939807-28-0(Hazardous Substances Data)

Upstream product

• 157665-51-5 3-fluoro-4-nitrobenzoyl chloride 
• 6148-64-7 ethyl potassium malonate 

Downstream Products

• 939807-29-1 ethyl 2-(3-fluoro-4-nitrobenzoyl)-3-(dimethylamino)acrylate 

Relevant articles and documents

PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE

This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of

PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE

This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of

SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS

This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds and compositions for the prevention and/or treatment of hyper-proliferative disorders and diseases associated with angiogenesis.